These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 18614582)
1. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. Ng AK; Zhang H; Tan K; Li Z; Liu JH; Chan PK; Li SM; Chan WY; Au SW; Joachimiak A; Walz T; Wang JH; Shaw PC FASEB J; 2008 Oct; 22(10):3638-47. PubMed ID: 18614582 [TBL] [Abstract][Full Text] [Related]
2. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Ye Q; Krug RM; Tao YJ Nature; 2006 Dec; 444(7122):1078-82. PubMed ID: 17151603 [TBL] [Abstract][Full Text] [Related]
3. Structure and sequence analysis of influenza A virus nucleoprotein. Ng AK; Wang JH; Shaw PC Sci China C Life Sci; 2009 May; 52(5):439-49. PubMed ID: 19471866 [TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities. Chan WH; Ng AK; Robb NC; Lam MK; Chan PK; Au SW; Wang JH; Fodor E; Shaw PC J Virol; 2010 Jul; 84(14):7337-45. PubMed ID: 20463064 [TBL] [Abstract][Full Text] [Related]
5. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Roy S; Kobinger GP; Lin J; Figueredo J; Calcedo R; Kobasa D; Wilson JM Vaccine; 2007 Sep; 25(39-40):6845-51. PubMed ID: 17728024 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus. Tarus B; Bertrand H; Zedda G; Di Primo C; Quideau S; Slama-Schwok A J Biomol Struct Dyn; 2015 Sep; 33(9):1899-912. PubMed ID: 25333630 [TBL] [Abstract][Full Text] [Related]
7. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Lei H; Peng X; Jiao H; Zhao D; Ouyang J Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406 [TBL] [Abstract][Full Text] [Related]
8. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973 [TBL] [Abstract][Full Text] [Related]
9. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target. Davis AM; Ramirez J; Newcomb LL Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821 [TBL] [Abstract][Full Text] [Related]
10. Structure of an H3N2 influenza virus nucleoprotein. Knight ML; Fan H; Bauer DLV; Grimes JM; Fodor E; Keown JR Acta Crystallogr F Struct Biol Commun; 2021 Jul; 77(Pt 7):208-214. PubMed ID: 34196611 [TBL] [Abstract][Full Text] [Related]
11. Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development. Liu CL; Hung HC; Lo SC; Chiang CH; Chen IJ; Hsu JT; Hou MH Sci Rep; 2016 Feb; 6():21662. PubMed ID: 26916998 [TBL] [Abstract][Full Text] [Related]
12. The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment. Hanke L; Knockenhauer KE; Brewer RC; van Diest E; Schmidt FI; Schwartz TU; Ploegh HL mBio; 2016 Dec; 7(6):. PubMed ID: 27965447 [TBL] [Abstract][Full Text] [Related]
13. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice. Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and structural evidence in support of a coherent model for the formation of the double-helical influenza A virus ribonucleoprotein. Ye Q; Guu TS; Mata DA; Kuo RL; Smith B; Krug RM; Tao YJ mBio; 2012 Dec; 4(1):e00467-12. PubMed ID: 23269829 [TBL] [Abstract][Full Text] [Related]
15. Crystal structures of influenza nucleoprotein complexed with nucleic acid provide insights into the mechanism of RNA interaction. Tang YS; Xu S; Chen YW; Wang JH; Shaw PC Nucleic Acids Res; 2021 Apr; 49(7):4144-4154. PubMed ID: 33784403 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for RNA binding and homo-oligomer formation by influenza B virus nucleoprotein. Ng AK; Lam MK; Zhang H; Liu J; Au SW; Chan PK; Wang J; Shaw PC J Virol; 2012 Jun; 86(12):6758-67. PubMed ID: 22496219 [TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics studies of the nucleoprotein of influenza A virus: role of the protein flexibility in RNA binding. Tarus B; Chevalier C; Richard CA; Delmas B; Di Primo C; Slama-Schwok A PLoS One; 2012; 7(1):e30038. PubMed ID: 22272272 [TBL] [Abstract][Full Text] [Related]
18. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge. Gao X; Wang W; Li Y; Zhang S; Duan Y; Xing L; Zhao Z; Zhang P; Li Z; Li R; Wang X; Yang P Antiviral Res; 2013 Apr; 98(1):4-11. PubMed ID: 23416215 [TBL] [Abstract][Full Text] [Related]
20. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens. Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]